Fastinov
2 known investors
Find your way into Fastinov
FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.
Investors · 2
Competitors · 4
by search overlap
BioMérieux6 shared keywordsbioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.
Affinity Biosensors4 shared keywordsAffinityBio develops LifeScale, a diagnostic system that uses population-profiling technology to identify Gram-negative bacteria in positive blood cultures and perform antibiotic susceptibility testing in roughly 4.5 hours. The system automates sample inoculation, incubation, reading, and reporting for clinical microbiology labs.
iFAST3 shared keywordsiFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process. The company serves clinical laboratories and hospitals to help combat antimicrobial resistance.
Oup3 shared keywordsOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Companies competing with Fastinov for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Fastinov do?
- FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.
- Who are Fastinov's investors?
- Fastinov's investors include Armilar Venture Partners, Bynd Venture Capital.